US Stock MarketDetailed Quotes

CGTX Cognition Therapeutics

Watchlist
  • 0.398
  • -0.007-1.63%
Close Nov 27 16:00 ET
  • 0.376
  • -0.022-5.48%
Post 20:01 ET
16.53MMarket Cap-414P/E (TTM)

Cognition Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cognition Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Cognition Therapeutics Earnings Reports

  • Cognition Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 07:48 ET

  • Cognition Therapeutics | 8-K: Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update

    Nov 13 07:43 ET

  • Cognition Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:19 ET

  • Cognition Therapeutics | 8-K: Cognition Therapeutics Reports Financial Results for the Second Quarter 2024 and Provides Business and Clinical Update

    Aug 8 07:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 28, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data